RICTOR and invasive breast carcinoma: Although at least one report suggests elevated Rictor levels correlate with higher overall and recurrence-free survival [51], Rictor overexpression was observed in clinical invasive breast cancer specimens relative to normal breast tissue, as well as in lymph node metastases [18], supporting the clinical relevance of mTORC2 in invasive breast cancer.